ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings
  • Abstract Number: 199 • 2018 ACR/ARHP Annual Meeting

    Evaluating the Perception Among Rheumatologists of Maintenance of Board Certification Programs in the United States

    Amr H Sawalha and Patrick Coit, Division of Rheumatology, University of Michigan, Ann Arbor, MI

    Background/Purpose: There continues to be a debate about the value and purpose of maintenance of certification programs (MOC) created by board-certifying organizations. Physicians, echoed by…
  • Abstract Number: 200 • 2018 ACR/ARHP Annual Meeting

    Validation of the Ers-RA Risk Score in a Dutch Population

    Milad Baniaamam1 and Michael Nurmohamed2, 1Department of rheumatology, Amsterdam Rheumatology immunology Center | Reade and VU University Medical Center Amsterdam, Netherlands, Amsterdam, Netherlands, 2Rheumatology, VU University Medical Center, Amsterdam, Netherlands

     Background/Purpose: The most frequent cause of death in patients with chronic rheumatoid arthritis (RA) is of cardiovascular (CV) origin. CV risk prediction scores in the…
  • Abstract Number: 201 • 2018 ACR/ARHP Annual Meeting

    Occupational Exposure to Coal and Silica Dust Is Associated with Elevated Risk of Rheumatoid Arthritis in Coal Mining Areas of US

    Laura Trupin1, Edward H. Yelin2, Gabriela Schmajuk3 and Paul Blanc4, 1University of California San Francisco, San Francisco, CA, 2Medicine/Rheumatology, University of California San Francisco, San Francisco, CA, 3San Francisco VA Medical Center, San Francisco, CA, 4Medicine, University of California San Francisco, San Francisco, CA

    Background/Purpose:  Exposure to inhaled mineral dust, particularly silica, has been associated with increased risk of RA and other autoimmune diseases. Coal mining leads to silica…
  • Abstract Number: 202 • 2018 ACR/ARHP Annual Meeting

    Risk of Inflammatory Arthritis Development in the Family Members of Indigenous North American (INA) RA Patients

    Stacy Tanner1, Irene Smolik2, Brenden Dufault3, Carol Hitchon3, David Robinson1, Elizabeth Ferucci4 and Hani El-Gabalawy3, 1Rheumatology, University of Manitoba, Winnipeg, MB, Canada, 2Arthritis Center, University of Manitoba, Winnipeg, MB, Canada, 3University of Manitoba, Winnipeg, MB, Canada, 4Alaska Native Medical Center, Anchorage, AK

    Background/Purpose: INA populations have a high prevalence of seropositive RA, often with severe disease. The risk of RA in family members of RA patients, particularly…
  • Abstract Number: 203 • 2018 ACR/ARHP Annual Meeting

    Meat Consumption and Risk of Rheumatoid Arthritis in Women: A Population-Based Cohort Study

    Daniela Di Giuseppe1, Lotta Ljung2 and Bjorn Sundstrom2, 1Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden, 2Department of Public Health and Clinical Medicine/Rheumatology,, Umeå University, Umeå, Sweden

    Background/Purpose: Mixed results have been reported for the association between meat consumption and the risk of developing rheumatoid arthritis (RA). The aim of this study…
  • Abstract Number: 204 • 2018 ACR/ARHP Annual Meeting

    Investigating Asthma, Allergic Disease, Passive Smoke Exposure, and Risk of Rheumatoid Arthritis

    Vanessa L. Kronzer1, Cynthia S. Crowson2, Jeffrey A. Sparks3, Robert Vassallo4 and John M. Davis III5, 1Internal Medicine, Mayo Clinic, Rochester, MN, 2Health Sciences Research, Mayo Clinic College of Medicine and Science, Rochester, MN, 3Division of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, Boston, MA, 4Pulmonary and Critical Care Medicine, Mayo Clinic, Rochester, MN, 5Division of Rheumatology, Mayo Clinic College of Medicine and Science, Rochester, MN

    Background/Purpose: Several studies show an association between asthma and RA. However, none have controlled for allergic disease, urban environment, or passive smoke exposure. We aimed…
  • Abstract Number: 205 • 2018 ACR/ARHP Annual Meeting

    Circulating Plasma Metabolites and Risk of Rheumatoid Arthritis in the Nurses Health Study

    Su Chu1,2, Jeffrey A. Sparks1,3, Jing Cui4, Sara K. Tedeschi3,5, Cameron Speyer3, Cianna Leatherwood1,3, Medha Barbhaiya6, Clary Clish7, Kevin D. Deane8, Jessica Su1,2, Karen Costenbader1,3 and Elizabeth Karlson1,9, 1Medicine, Harvard Medical School, Boston, MA, 2Channing Division of Network Medicine, Brigham and Women's Hospital, Boston, MA, 3Division of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, Boston, MA, 4Rheumatology and Immunology, Brigham and Women's Hospital, Boston, MA, 5American College of Rheumatology, Atlanta, GA, 6Rheumatology, Hospital for Special Surgery, Weill Cornell Medicine, New York, NY, 7Broad Institute of MIT and Harvard, Boston, MA, 8Division of Rheumatology, University of Colorado Denver, Aurora, CO, 9Rheumatology/Immunology, Brigham and Women's Hospital, Boston, MA

    Background/Purpose: Rheumatoid arthritis (RA) develops insidiously, often over many years. Given that diet and obesity have been associated with increased RA risk, we investigated whether…
  • Abstract Number: 206 • 2018 ACR/ARHP Annual Meeting

    Impact of International Classification of Diseases 10th Revision Codes and Updated Medical Information on an Existing Rheumatoid Arthritis Phenotype Algorithm Using Electronic Medical Data

    Sicong Huang1, Jie Huang1, Tianrun Cai2, Kumar P. Dahal3, Andrew Cagan4, Jacklyn Stratton3, Tianxi Cai5 and Katherine P. Liao3, 1Division of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, Boston, MA, 2Rheumatology, Immunology, and Allergy, Brigham and Women's Hospital, Boston, MA, 3Brigham and Women's Hospital, Boston, MA, 4Research Computing, Partners HealthCare, Charlestown, MA, 5Harvard T.H. Chan School of Public Health, Boston, MA

    Background/Purpose: Electronic medical records (EMRs) are increasingly being utilized for clinical research, where the phenotypes of interest are typically defined by algorithms.  Almost a decade…
  • Abstract Number: 207 • 2018 ACR/ARHP Annual Meeting

    Divergent Patterns of Cardiovascular Risk in Biomarkers of Lipids and Subclinical Myocardial Injury during Increased Inflammation in Rheumatoid Arthritis

    Katherine P. Liao1, Jie Huang2, Gabrielle Cremone3, Ethan Lam3, Nicole Yang1, Martin Playford4, Christine K Iannaccone1, Jonathan Coblyn5, Elena Massarotti1, Michael E Weinblatt5, Nancy A. Shadick1, Nehal Mehta4 and Jorge Plutzky1, 1Brigham and Women's Hospital, Boston, MA, 2Division of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, Boston, MA, 3Rheumatology, Brigham and Women's Hospital, Boston, MA, 4NHLBI, Bethesda, MD, 5Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, Boston, MA

    Background/Purpose: Inflammation is an independent risk factor for cardiovascular (CV) risk in rheumatoid arthritis (RA). Paradoxically, potentially cardioprotective decreases in inflammation is associated with increased…
  • Abstract Number: 208 • 2018 ACR/ARHP Annual Meeting

    Antibodies to Citrullinated Protein Antigens Are Associated with Risk of Cardiovascular Disease in Community-Dwelling Women: The Multi-Ethnic Study of Atherosclerosis

    Jan M. Hughes-Austin1, Ronit Katz2, Gary S. Firestein3, Michael H. Criqui4, William H. Robinson5 and Joachim H. Ix6, 1Orthopaedic Surgery, University of California, San Diego, La Jolla, CA, 2University of Washington, Seattle, WA, 3Medicine, University of California San Diego, La Jolla, CA, 4Family Medicine and Public Health, University of California, San Diego, La Jolla, CA, 5Stanford, Stanford, CA, 6Nephrology-Hypertension, University of California, San Diego, La Jolla, CA

    Antibodies to Citrullinated Protein Antigens are Associated with Risk of Cardiovascular Disease in Community Dwelling Women: The Multi-Ethnic Study of Atherosclerosis Background/Purpose: Risk for cardiovascular…
  • Abstract Number: 209 • 2018 ACR/ARHP Annual Meeting

    Development of an Algorithm for the Classification of Cardiovascular Comorbidity in Rheumatoid Arthritis: Data from the Ontario Best Practices Research Initiative

    Kangping Cui1,2, Mohammad Movahedi3, Claire Bombardier4 and Bindee Kuriya5, 1Internal Medicine, University of Western Ontario, London, ON, Canada, 2Toronto General Hospital Research Institute, Toronto, ON, Canada, 3JSS Medical Research, St-Laurent, QC, Canada, 4Toronto General Hospital Research Institute, University Health Network, Toronto, ON, Canada, 5Rheumatology, Mount Sinai Hospital, University of Toronto, Toronto, ON, Canada

    Development of an Algorithm for the Classification of Cardiovascular Comorbidity in Rheumatoid Arthritis: Data from the Ontario Best Practices Research InitiativeBackground/Purpose: Cardiovascular disease (CVD) is…
  • Abstract Number: 210 • 2018 ACR/ARHP Annual Meeting

    Changes in Alcohol Use in Patients with Rheumatoid Arthritis: Associations with Disease Activity, Health Status, and Mortality

    Joshua Baker1, Harlan Sayles2, Bryant R. England3, Ted R. Mikuls4 and Kaleb Michaud5, 1Corporal Michael J. Crescenz VA Medical Center, Philadelphia, PA, 2University of Nebraska Medical Center, Omaha, NE, 3Rheumatology, VA Nebraska-Western Iowa Health Care System & University of Nebraska Medical Center, Omaha, NE, 4Internal Medicine, Division of Rheumatology, VA Nebraska-Western Iowa Health Care System and University of Nebraska Medical Center, Omaha, NE, 5Rheumatology, University of Nebraska Medical Center, Omaha, NE

    Background/Purpose: Prior studies observed better disease control, quality of life, and physical function among patients with rheumatoid arthritis (RA) who drink alcohol. These studies may…
  • Abstract Number: 211 • 2018 ACR/ARHP Annual Meeting

    Excess in Prevalence of Functional Disability in Patients with Rheumatoid Arthritis: Does Serologic Status Matter?

    Elena Myasoedova1, John M. Davis III1, Sara J. Achenbach2, Eric L. Matteson1 and Cynthia S. Crowson2, 1Division of Rheumatology, Mayo Clinic College of Medicine and Science, Rochester, MN, 2Health Sciences Research, Mayo Clinic College of Medicine and Science, Rochester, MN

    Background/Purpose: Despite the advances in treatment of rheumatoid arthritis (RA) over the recent decades, many patients with RA do not achieve remission or full physical…
  • Abstract Number: 212 • 2018 ACR/ARHP Annual Meeting

    Mortality and Causes of Death in Patients with Inflammatory Arthritis in Hong Kong over 20 Years

    Tommy Tsang Cheung, Simon Man Fung Tsoi, Bernard Man Yung Cheung and Chak Sing Lau, Medicine, The University of Hong Kong, Hong Kong, Hong Kong

    Background/Purpose: Patients with inflammatory arthritis have a higher mortality than the general population due to increased risks of cardiovascular diseases, infection and cancer. As the…
  • Abstract Number: 213 • 2018 ACR/ARHP Annual Meeting

    Excessive Risk of Major Cardiovascular Events in Sero-Positive Rheumatoid Arthritis and in Patients with Active Disease

    Annette de Thurah1,2, Ina Trolle Andersen3, Andreas Bugge Tingaard4, Josephine Therkildsen5, Anders Hammerich Riis3, Morten Böttcher5 and Ellen-Margrethe Hauge6,7, 1Department of Rheumatology, Aarhus University Hospital, Århus C, Denmark, 2Department of Clinical Medicine, Aarhus University, Aarhus, DK, Aarhus N, Denmark, 3Department of Clinical Epidemiology, Aarhus University Hospital, Aarhus, Denmark, 4Department of Cardiology, Regional Hospital of Herning, Herning, Denmark, 5Cardiology, Regional Hospital of Herning, Herning, Denmark, 6Department of Rheumatology, Department of Rheumatology, Aarhus University Hospital, Aarhus, Denmark, 7Department of Clinical Medicine, Aarhus University, Aarhus C, Denmark

    Background/Purpose: Rheumatoid arthritis (RA) is a known risk factor for the development of cardiovascular disease (CVD). However, the influence of RA on the prognosis after…
  • « Previous Page
  • 1
  • …
  • 1016
  • 1017
  • 1018
  • 1019
  • 1020
  • …
  • 2425
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology